The presence of left bundle branch block (LBBB) is an electrocardiographic finding with potentially important implications that are closely linked to a patient's clinical presentation. The clinical significance, predictive impact, and therapeutic considerations related to the identification of LBBB vary distinctly across a wide spectrum of cardiac disease ranging from a presumably benign finding among apparently healthy individuals to an equivalent of myocardial ischemia in the setting of acute chest pain to a manifestation of advanced ventricular dysfunction in patients with heart failure. 1,2 Although LBBB is encountered frequently in everyday clinical practice, defining the diagnostic and prognostic significance and thus the optimal management of patients with this electrocardiographic abnormality frequently poses challenges and dilemmas to the practicing clinician, particularly in 2 clinical settings: in asymptomatic individuals and in patients presenting to the emergency department with symptoms suggestive of an acute coronary event.
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Accumulating evidence from large-scale epidemiological studies has provided important insights into the prevalence, natural history, and clinical correlates of LBBB in apparently healthy individuals. The prevalence of LBBB has been estimated around 0.1% to 0.4% in middle-age men in unselected populations. 1,2 A consistent finding of relevant investigations is that the prevalence of this conduction abnormality increases progressively with advancing age, with a reported prevalence <1% at the age of 50 rising to more than 6% or even 17% among octogenarians. 2, 3 Of note, LBBB appears to be less prevalent than isolated right bundle branch block. 4 The increasing prevalence of LBBB with advancing age and the literal absence among younger individuals <35 years of age (with the exception of rare cases accompanying congenital structural abnormalities of the heart) may be interpreted as an indication of an acquired disorder that usually occurs later in life. Along these lines, the concept that LBBB likely represents a degenerative process of the conduction system is substantiated by the close association of LBBB development with cardiovascular (CV) risk factors and comorbidities including arterial hypertension, valvular heart disease, left ventricular hypertrophy, cardiomyopathies, and ischemic heart disease (IHD) in the majority of cases. 3, 5, 6 The occurrence of LBBB even without any evident comorbidities and predisposing factors is a rather infrequent, yet challenging exception in this respect.
Whether newly diagnosed LBBB in asymptomatic and apparently healthy individuals portends unfavorable CV outcomes and is associated with increased mortality compared with individuals with normal intraventricular conduction has been somewhat controversial. Population-based studies have demonstrated an increase in mortality, sudden cardiac death, IHD, and heart failure in individuals with LBBB compared with those without LBBB. [7] [8] [9] Imanishi et al showed in a cohort of more than 17 000 Japanese individuals followed over 40 years that LBBB independently predicted cardiac mortality after controlling for age, gender, and underlying diseases. 3 Individuals with acquired LBBB in the Framingham Study were more likely to develop manifest CV disease; this was particularly evident among men, in whom the appearance of LBBB contributed to an increased risk of CV mortality. 10 Consistent findings were demonstrated in the Manitoba Heart Study, where individuals with LBBB had a substantially higher risk of sudden death. 9 One lesson learned from the Framingham study, however, is that in the general adult population, newly acquired LBBB is most often a hallmark of hypertensive or IHD or both, which likely accounts for the associated unfavorable outcomes. 10 Along these lines, prognosis related to LBBB appears to be more favorable among individuals at a relatively younger age without CV risk factors. 8 Other investigations have shown somewhat conflicting results by demonstrating that the presence of LBBB per se did not independently predict mortality after adjustment for possible confounders. 4 The large-scale Reykjavik study, for example, found that mortality from IHD or hypertension was not increased among those with LBBB in a cohort of 17 000 patients followed over 10 years. 1 Together these observations suggest that LBBB can occur either as an isolated, intrinsic dysfunction of the conduction system or more frequently as a consequence of external CV factors, and also that the ominous prognosis attributed to the presence of the block is most likely driven by the confounding effect of concomitant comorbidities and risk factors.
Patients presenting with suspicion of an acute coronary syndrome and LBBB represent a major challenge in everyday clinical practice. The prevalence of LBBB ranges between 1% and 9% among patients presenting to the emergency department with chest pain and suspected myocardial infarction (MI). [11] [12] [13] [14] [15] Diagnosis of MI is obscured by the fact that typical electrocardiogram (ECG) signs of ischemia are masked by the presence of LBBB. The delayed transmission of the cardiac electric impulse, delayed ventricular depolarization, and altered direction of initial septal activation of the left ventricular myocardium in the presence of LBBB result in absence of septal Q waves, whereas ST-segment abnormalities secondary to LBBB mask ischemic injury currents that are essential for diagnosis of acute myocardial ischemia. Interestingly, notwithstanding the difficulty of identifying acute myocardial ischemia in the presence of LBBB, growing evidence points to the pitfall of over-(rather than under-) diagnosing MI in this setting. Because of the limited specificity of LBBB to identify myocardial ischemia, the presence of true MI in this setting may actually be lower than previously appreciated. 16 From a pathophysiological standpoint, given the dual blood supply of the left bundle for the left and right coronary arteries, an MI is not very likely to cause acute LBBB; hence, it is postulated that LBBB is often a bystander, preexisting anomaly rather than a direct result of acute ischemia. The concept that new LBBB in the setting of clinically suspected myocardial ischemia represents an equivalent of ST-segment elevation MI (STEMI) has been questioned by studies assessing biomarker elevation and angiographic confirmation of STEMI in this setting. 17, 18 Indeed, a sizable proportion of patients with presumed new LBBB are not confirmed to have arterial occlusion and thus rather represent non-STEMI, unstable angina, or noncardiac causes of acute chest pain. 19, 20 Definitive confirmation of MI in the presence of LBBB is of critical importance, since patients with STEMI benefit substantially from immediate reperfusion, whereas inappropriate use of reperfusion therapies-particularly fibrinolysis-is linked to an increased risk of complications. Electrocardiographic signs have been proposed to facilitate the identification of underlying ischemia and thus aid the diagnosis of MI in patients with LBBB. The Sgabrossa criteria, introduced in 1996 based on an analysis of the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-1) trial, have a reported sensitivity of 78% and specificity of 90% for detection of STEMI. 21 Subsequent validation studies confirmed the high specificity but demonstrated a lower sensitivity of these criteria, [22] [23] [24] [25] which are used mostly to diagnose MI in the setting of known, preexisting LBBB rather than for the differential diagnosis of patients with suspected myocardial ischemia and presumed new LBBB. Those criteria are not included in current guidelines for diagnosis of STEMI. Overall, in the absence of electrocardiographic criteria to definitively identify or exclude acute myocardial ischemia in the presence of LBBB and despite evidence dissociating LBBB from STEMI in a substantial proportion of patients, [17] [18] [19] [20] individuals with presumed new LBBB and strong clinical suspicion of MI are currently recommended to undergo prompt reperfusion therapy. 26 Of note, these recommendations are mostly based on previous data from older thrombolysis trials showing the beneficial effect of reperfusion therapy in patients with LBBB and suspected MI, yet they are applied in the current era of primary percutaneous coronary intervention and indeed suggest interventional rather that fibrinolytic therapy, if feasible, to avert the bleeding hazard associated with thrombolysis. 26 Similar to the conundrum of the true prognostic significance of LBBB in apparently healthy individuals, uncertainty remains regarding the prognostic impact of LBBB in the setting of MI. Mortality and subsequent development of heart failure have been reported to be higher in patients with MI with LBBB, 27, 28 probably reflecting higher ischemic burden. One alternative explanation, however, of the reportedly worse outcomes in patients with LBBB as an electrocardiographic manifestation of MI may be less aggressive management and delayed reperfusion, and overall lower reperfusion rates of these patients due to the uncertainty of definitive diagnosis of MI in the presence of LBBB. Of note, not all studies have confirmed an increased risk conferred by the presence of LBBB per se in this setting, indicating that LBBB is more of a marker of underlying myocardial dysfunction rather than an independent predictor of mortality following MI. 29, 30 In a recent issue of Angiology, Alkindi and colleagues analyzed the clinical correlates and the final diagnosis in 768 patients with LBBB among 50 992 patients hospitalized for acute cardiac events over a 23-year evaluation period in Qatar. 31 They found that patients with LBBB were older, more often male, and with more comorbidities (hypertension, diabetes, and chronic renal failure) compared with patients without LBBB. Irrespective of presenting symptoms, the most frequent cause of admission in patients with LBBB was heart failure, followed by an acute coronary syndrome. Importantly, presence of LBBB along with chronic renal failure predicted in-hospital mortality. This investigation provides insights regarding the relative incidence of cardiac ischemia versus chronic heart failure in real-world patients presenting in an emergency setting with LBBB, and it particularly highlights that LBBB upon presentation in an acute setting does not necessarily equal acute myocardial ischemia. An analysis of final diagnosis in conjunction to clinical presentation (acute chest pain vs dyspnea) in these patients with LBBB by Alkindi et al would have provided additional insights in this respect, since in the current analysis valuable information may be diluted by disregarding the pattern of initial clinical symptoms under the general description of acute cardiac events.
Identification of LBBB remains a challenging finding in everyday practice. Patients with LBBB encompass a substantially heterogeneous population ranging from apparently healthy individuals to patients with acute coronary events to advanced heart failure 32 ; consistently, the clinical importance of LBBB varies from an incidental finding likely without clinical sequelae to degeneration of the conduction system in the setting of advanced age and CV risk factors to a lifethreatening emergency that requires immediate coronary reperfusion. Given the uncertainty of diagnosis of the underlying CV abnormality in a proportion of patients with LBBB-particularly those presenting in an emergent setting-cautious interpretation of this electrocardiographic abnormality is required. A tailored, patient-oriented approach that would also incorporate evaluation of cardiac biomarkers, comparison with previous ECGs if available to determine whether the LBBB is indeed new (and thus the likelihood of ongoing ischemia is high), cardiac imaging (e.g., bedside echocardiographic evaluation for immediate assessment of possible cardiac structural and functional abnormalities), and above all clinical judgment may facilitate correct diagnosis, enhance risk-stratification, and guide overall management of patients with LBBB.
